Clinical trial
Level of Satisfaction and Quality of Life in People Living With HIV in Chile, Who Switch From Oral Therapy to Long-acting Injectable Cabotegravir + Rilpivirine
NCT05835635 is registered in ClinicalTrials.gov with Pontificia Universidad Catolica de Chile as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Level of Satisfaction and Quality of Life in People Living With HIV in Chile, Who Switch From Oral Therapy to Long-acting Injectable Cabotegravir + Rilpivirine
- Lead sponsor
- Pontificia Universidad Catolica de Chile
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- May 1, 2025
- Completion date
- May 1, 2026
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acceptability of health care, patient preference, patient satisfaction, quality of life